Backbone modified oligonucleotide analogues
AssigneeIsis Pharmaceuticals, Inc.
InventorsPhillip D. Cook, Yogesh S. Sanghvi, Jean J. Vasseur, Francoise Debart
Life of this patent
Estimating the term…
Abstract
Therapeutic oligonucleotide analogues which have improved nuclease resistance and improved cellular uptake are provided. Replacement of the normal phosphorodiester inter-sugar linkages found in natural oligomers with four atom linking groups forms unique di- and poly- nucleosides and nucleotides useful in regulating RNA expression and in therapeutics. Methods of synthesis and use are also disclosed.
Claims29
An oligonucleotide analogue in which at least one of the subunits of the analogue have the structure:
- ##STR9## wherein B.sub.X is a variable base;
- Q is O;
- X is H;
- OH;
- C.sub.1 to C.sub.10 lower alkyl, substituted lower alkyl, alkaryl or aralkyl;
- F;
- Cl;
- Br;
- CN;
- CF.sub.3 ;
- OCF.sub.3 ;
- OCN;
- O-, S-, or N-alkyl;
- O-, S-, or N-alkenyl;
- SOCH.sub.3 ;
- SO.sub.2 CH.sub.3 ;
- ONO.sub.2 ;
- NO.sub.2 ;
- N.sub.3 ;
- NH.sub.2 ;
- heterocycloalkyl;
- heterocycloalkaryl;
- aminoalkylamino;
- polyalkylamino;
- or substituted silyl;
- L.sub.1, L.sub.2, L.sub.3, and L.sub.4 are selected such that:
- i. L.sub.1 and L.sub.4 are, independently, CH.sub.2, C.dbd.O, C.dbd.S, C-NH.sub.2, C-NHR.sub.3, C-OH, C-SH, C-O-R.sub.1 or C-S-R.sub.4 ;
- and
- L.sub.2 and L.sub.3 are, independently, CR.sub.1 R.sub.2, C.dbd.CR.sub.1 R.sub.2, C.dbd.NR.sub.3, P(O)R.sub.4, P(S)R.sub.4, C.dbd.O, C.dbd.S, O, S, SO, SO.sub.2, NR.sub.3 or SiR.sub.5 R.sub.6 ;
- or, together, form part of an alkene, alkyne, aromatic ring, carbocycle or heterocycle;
- or
- ii. L.sub.1, L.sub.2, L.sub.3 and L.sub.4, together, form a -CH.dbd.N-NH-CH.sub.2 - or -CH.sub.2 -O-N.dbd.CH- moiety;
- R.sub.1 and R.sub.2 are, independently, H;
- OH;
- SH;
- NH.sub.2 ;
- C.sub.1 to C.sub.10 alkyl, substituted alkyl, alkenyl, alkaryl or aralkyl;
- alkoxy;
- thioalkoxy;
- alkylamino;
- aralkylamino;
- substituted alkylamino;
- heterocycloalkyl;
- heterocycloalkylamino;
- aminoalkylamino;
- polyalkylamino;
- halo;
- formyl;
- keto;
- benzoxy;
- carboxamido;
- thiocarboxamido;
- ester;
- thioester;
- carboxamidine;
- carbamyl;
- ureido;
- or guanidino;
- R.sub.3 is H, OH, NH.sub.2, lower alkyl, substituted lower alkyl, alkoxy, lower alkenyl, aralkyl, alkylamino, aralkylamino, substituted alkylamino, heterocyclocalkyl, heterocycloalkylamino, aminoalkylamino, or polyalkylamino;
- R.sub.4 is OH, SH, NH.sub.2, O-alkyl, S-alkyl, NH-alkyl, O-alkylheterocyclo, S-alkylheterocyclo, N-alkylheterocyclo or a nitrogen-containing heterocycle;
- and
- R.sub.5 and R.sub.6 are, independently, C.sub.1 to C.sub.6 alkyl or alkoxy;
- provided that:
- if L.sub.1 is C.dbd.O or C.dbd.S then L.sub.2 is not NR.sub.3 ;
- if L.sub.4 is C.dbd.O or C.dbd.S then L.sub.3 is not NR.sub.3 ;
- if one of L.sub.2 or L.sub.3 is C.dbd.O or C.dbd.S then the other of L.sub.2 or L.sub.3 is not NR.sub.3 ;
- if L.sub.1 is CH.sub.2 and L.sub.2 is P(O)R.sub.4 and R.sub.4 is OH then L.sub.3 is not O;
- or if L.sub.1, L.sub.2 and L.sub.4 are CH.sub.2 and X is H or OH then L.sub.3 is not S, SO or SO.sub.2.
The oligonucleotide analogue of claim 18 wherein L.sub.1 and L.sub.4 are each CH.sub.2.
A nucleoside having the structure:
- ##STR10## wherein B.sub.X is a variable base;
- Q is O;
- X is H;
- OH;
- C.sub.1 to C.sub.10 lower alkyl, substituted lower alkyl, alkaryl or aralkyl;
- F;
- Cl;
- Br;
- CN;
- CF.sub.3 ;
- OCF.sub.3 ;
- OCN;
- O-, S-, or N-alkyl;
- O-, S-, or N-alkenyl;
- SOCH.sub.3 ;
- SO.sub.2 CH.sub.3 ;
- ONO.sub.2 ;
- NO.sub.2 ;
- N.sub.3 ;
- NH.sub.2 ;
- heterocycloalkyl;
- heterocycloalkaryl;
- aminoalkylamino;
- polyalkylamino;
- or substituted silyl;
- y is hydroxyl, aminomethyl, hydrazinomethyl, hydroxymethyl, C-formyl, phthalimidohydroxymethyl, aryl-substituted imidazolidino, aminohydroxylmethyl, ortho-methylaminobenzenethio, methylphosphonate and methylalkylphosphonate;
- Z is H, hydroxyl, aminomethyl, hydrazinomethyl, hydroxymethyl, C-formyl, phthalimidohydroxymethyl, aryl substituted imidazolidino, aminohydroxylmethyl, ortho methylaminobenzenethio, methylphosphonate or methyl alkylphosphonate;
- provided that when y is hydroxymethyl then Z is not H, hydroxyl, or C-formyl;
- and
- further provided that when X is H or OH and Z is hydroxyl then y is not aminohydroxylmethyl, hydrazinomethyl or aryl-substituted imidazolidino.
Dependencies are inferred from the claim text.